BPC-157 vs TB-500: Which Repair Peptide for Your Research?
Published 2026-06-08 · 6 min read
BPC-157 and TB-500 are the two most-cited repair peptides in contemporary research. They are sometimes treated as interchangeable, but they have different origins, different mechanisms, and different research model strengths. This article compares them across the axes that matter for protocol design.
At a glance
| BPC-157 | TB-500 | |
|---|---|---|
| Class | Pentadecapeptide (15 amino acids) | Synthetic fragment of Thymosin Beta-4 |
| Origin | Derived from a protective protein in human gastric juice | Active fragment of naturally occurring Thymosin Beta-4 protein |
| Primary mechanism studied | Cytoprotection, angiogenesis, nitric oxide modulation, growth-factor support | Actin sequestration, angiogenesis, cell migration, wound coverage |
| Half-life | Short systemic half-life; stable in gastric juice | Longer systemic half-life than BPC-157 |
| Most-studied research models | Tendon, ligament, gastrointestinal tissue, ulcer healing models | Cardiac tissue, dermal wound healing, ocular and corneal models |
| Solubility | Highly soluble in bacteriostatic water; clean reconstitution | Highly soluble in bacteriostatic water |
| Typical research vial size | 10mg lyophilized | 10mg lyophilized |
BPC-157 — cytoprotection and connective tissue focus
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a stable fragment of a protective protein found in human gastric juice. Its research literature is dominated by gastrointestinal tissue models and connective tissue repair — particularly tendon and ligament work — alongside studies of nitric oxide modulation and growth factor signaling.
Best suited for research focused on tendon, ligament, or gastrointestinal mucosa endpoints, and for protocols where cytoprotection or growth-factor-related pathways are part of the hypothesis.
TB-500 — angiogenesis and cell migration focus
TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), the naturally occurring actin-sequestering protein. Its mechanism centers on actin binding and downstream effects on cell migration and tissue patterning. The literature emphasizes wound healing models, cardiac tissue, and dermal/ocular research applications.
Best suited for research focused on wound closure rate, angiogenesis, cell migration assays, and cardiac or dermal repair models.
Combined research use
The two peptides are frequently studied together because their mechanisms are complementary — BPC-157 contributes a cytoprotection and growth-factor arm; TB-500 contributes an angiogenic and cell migration arm. The combined protocol is one of the most common stack designs in repair-peptide research.
See our Recovery & Tissue Repair Stack for a pre-bundled combination of both compounds.
Choosing between them
- Tendon, ligament, or GI tissue research: BPC-157 is the primary choice.
- Wound healing, dermal, cardiac, or angiogenesis-focused research: TB-500 is more relevant.
- Combined repair protocols: use both in parallel arms or as a combined stack.
For the laboratory reconstitution protocol used for either compound, see How to Reconstitute BPC-157. The same materials and step-by-step procedure apply to TB-500.
For Research Use Only. Information presented for laboratory and research applications. Not medical advice and not a substitute for qualified scientific judgment.